; and (B) include— (i) a description of the activities carried out using the grant funds; (ii) a summary of the health outcomes for sickle cell patients benefitting from the transition coordination and management program supported by the grant; and (iii) the number of specialists trained and fellowships funded under the grant, as described in subsection (a)(2), as applicable. (2) Reporting by the Secretary Not later than 2 years after the date of enactment of the Sickle Cell Care Expansion Act of 2023 , and annually thereafter, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on activities carried out by eligible entities under this section, based on the reports submitted to the Secretary under paragraph (1). (e) Authorization of appropriations To carry out this section, there is authorized to be appropriated $70,000,000 for each of fiscal years 2024 through 2029. .